Bliss GVS Pharma

Bliss GVS Pharma Ltd Annually Results

NSEBSE

₹120.38

(-2.20%)

Apr 30, 2025|02:49:57 PM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Gross Sales	770.24	751.59	747.45	577.21	689.31
Excise Duty	0	0	0	0	0
Net Sales	770.24	751.59	747.45	577.21	689.31
Other Operating Income	0	0	0	0	0
Other Income	28.74	17.79	31.49	20.22	39.19
Total Income	798.98	769.37	778.95	597.43	728.49
Total Expenditure	648.82	634.27	702.71	470.56	579.37
PBIDT	150.16	135.11	76.24	126.87	149.12
Interest	6.91	10.36	4.74	5.51	7.57
PBDT	143.25	124.74	71.5	121.36	141.55
Depreciation	26.38	18.67	17.33	17.23	12.59
Minority Interest Before NP	0	0	0	0	0
Tax	33.26	40.84	35.78	28.92	36.81
Deferred Tax	2.03	-11.51	-4.74	1.23	-3.09
Reported Profit After Tax	81.58	76.73	23.13	73.97	95.25
Minority Interest After NP	6.12	5.88	8.09	5.48	-2.01
Net Profit after Minority Interest	75.45	70.86	15.04	68.49	97.27
Extra-ordinary Items	-20.38	0	-37.81	0	-9.56
Adjusted Profit After Extra-ordinary item	95.83	70.86	52.85	68.49	106.83
EPS (Unit Curr.)	7.23	6.83	1.46	6.64	9.43
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	50	50	50	50	50
Equity	10.47	10.42	10.37	10.31	10.31
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	19.49	17.97	10.2	21.97	21.63
PBDTM(%)	18.59	16.59	9.56	21.02	20.53
PATM(%)	10.59	10.2	3.09	12.81	13.81

No Record Found

Invest wise with Expert advice